Harbour Biomed Therapeutics Ltd., of Shanghai, and Erasmus Medical Center in Rotterdam, the Netherlands, signed a 10-year memorandum of understanding to enable a broad range of joint basic, translational and clinical research activities aimed at developing next-generation biotherapeutics for the treatment of cancer and immunological diseases.